VA

VR Adviser Portfolio holdings

AUM $2.68B
1-Year Est. Return 422.73%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+422.73%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.68B
AUM Growth
+$655M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$92.6M
2
+$28.9M
3
+$22.9M
4
TENX icon
Tenax Therapeutics
TENX
+$22.7M
5
ANL
Adlai Nortye
ANL
+$21.5M

Top Sells

1
+$41.6M
2
+$31.7M
3
+$28.3M
4
ERAS icon
Erasca
ERAS
+$17.4M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$15.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APGE icon
1
Apogee Therapeutics
APGE
$6.55B
$715M 26.68%
8,493,321
ERAS icon
2
Erasca
ERAS
$3.72B
$265M 9.89%
16,382,812
-1,474,271
ORKA
3
Oruka Therapeutics
ORKA
$3.63B
$203M 7.6%
4,148,428
SYRE icon
4
Spyre Therapeutics
SYRE
$6.4B
$186M 6.94%
3,685,448
KALV icon
5
KalVista Pharmaceuticals
KALV
$1.43B
$130M 4.86%
6,474,485
-254,500
DNTH icon
6
Dianthus Therapeutics
DNTH
$4.4B
$99M 3.7%
1,180,000
+180,000
DMRA
7
Damora Therapeutics
DMRA
$1.29B
$93.3M 3.48%
+3,603,595
OCUL icon
8
Ocular Therapeutix
OCUL
$1.81B
$87.6M 3.27%
10,346,926
+3,031,379
COGT icon
9
Cogent Biosciences
COGT
$5.3B
$77M 2.87%
2,000,000
VRDN icon
10
Viridian Therapeutics
VRDN
$1.74B
$75.9M 2.83%
3,882,709
SVRA icon
11
Savara
SVRA
$1.04B
$75M 2.8%
13,740,375
ELVN icon
12
Enliven Therapeutics
ELVN
$2.11B
$67.7M 2.53%
1,726,331
-1,500,000
ORIC icon
13
Oric Pharmaceuticals
ORIC
$776M
$54.7M 2.04%
4,319,765
-1,356,465
VOR icon
14
Vor Biopharma
VOR
$713M
$54.3M 2.03%
3,041,719
+1,097,953
MAZE
15
Maze Therapeutics
MAZE
$1.34B
$47.8M 1.78%
1,602,034
+53,465
CTMX icon
16
CytomX Therapeutics
CTMX
$653M
$46.9M 1.75%
9,982,124
-5,579,376
JBIO
17
Jade Biosciences
JBIO
$1.01B
$45.2M 1.69%
3,220,364
DYN icon
18
Dyne Therapeutics
DYN
$2.82B
$39.4M 1.47%
2,173,913
CBIO
19
Crescent Biopharma
CBIO
$496M
$39.2M 1.46%
2,133,576
ZURA icon
20
Zura Bio
ZURA
$323M
$38.3M 1.43%
6,434,990
+1,089,875
RLMD icon
21
Relmada Therapeutics
RLMD
$624M
$33.7M 1.26%
+4,843,380
ENGN icon
22
enGene Therapeutics
ENGN
$110M
$32.5M 1.21%
4,771,414
TENX icon
23
Tenax Therapeutics
TENX
$285M
$26.8M 1%
+1,675,262
ANL
24
Adlai Nortye
ANL
$641M
$22.2M 0.83%
+3,212,731
IPSC icon
25
Century Therapeutics
IPSC
$384M
$19.7M 0.73%
+8,695,652
1
2